Join +750K new investors every month who copy stock picks from billionaire's portfoliosSign Up Free

Ginkgo Bioworks shares plummet amid revenue decline and high valuation concerns

EditorAmbhini Aishwarya
Published 10/11/2023, 11:20
© Reuters.
DNA
-

In a notable shift in investor sentiment, shares of Ginkgo Bioworks Holdings, Inc. (NYSE:DNA), a key player in the US Chemicals industry, have experienced a significant downturn over the past year. The company's stock value took a sharp 30% dive within the last month, contributing to an overall 52% decline over the year.

Despite the company's high Price/Sales (P/S) ratio of 7.9x, which stands out in an industry where half of the companies boast P/S ratios below 1.2x, investors are showing signs of concern. This elevated ratio is particularly striking given that Ginkgo Bioworks' revenue has been shrinking at a rate that surpasses the industry average.

The company has faced a substantial 40% decrease in revenue last year, yet it had previously demonstrated impressive revenue growth over three years. Looking ahead, analysts remain optimistic about Ginkgo Bioworks' prospects, forecasting an ambitious annual growth rate of 25% for the next three years—a figure that would significantly exceed the industry's expected growth rate of 10%.

This positive outlook may explain why Ginkgo Bioworks maintains such a high P/S ratio and why some shareholders are hesitant to part with their shares. However, for the stock price to sustain its current level, these revenue growth projections need to materialize.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.